Antibody drug conjugates
US12221460B2 · kind B2 · utility
0Cited by
20References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2023 |
| Grant date | Feb 11, 2025 |
| Priority date | — |
| Expiry date | Jul 31, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y203/02013
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibody drug conjugates comprising STING modulators. Also provided are compositions comprising the antibody drug conjugates. The compounds and compositions are useful for stimulating an immune response in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.